{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:01:01Z","timestamp":1794186061862,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.05.089","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T02:53:16Z","timestamp":1354243996000},"page":"F24-F33","source":"Crossref","is-referenced-by-count":349,"special_numbering":"S5","title":["Updating the Natural History of Human Papillomavirus and Anogenital Cancers"],"prefix":"10.1016","volume":"30","author":[{"given":"Anna-Barbara","family":"Moscicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginesa","family":"Albero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K.","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2012.05.089_bib0005","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodriguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/CEJ.0b013e328324061a","article-title":"A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany","volume":"18","author":"Kovacs","year":"2009","journal-title":"Eur J Cancer Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0030","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ijc.25199","article-title":"Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling","volume":"127","author":"Moscicki","year":"2010","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0035","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","article-title":"A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia","volume":"70","author":"Schiffman","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0040","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/jiq116","article-title":"Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer","volume":"203","author":"Castle","year":"2011","journal-title":"J Infect Dis"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.05.089_bib0430","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of alpha human papillomaviruses","volume":"30","author":"Poljak","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.089_bib0050","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1158\/1055-9965.EPI-10-0424","article-title":"Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix","volume":"19","author":"Sundstrom","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0055","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ijc.25408","article-title":"Prospective study of human papillomavirus and risk of cervical adenocarcinoma","volume":"127","author":"Dahlstrom","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0065","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1158\/1055-9965.EPI-10-0394","article-title":"The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types","volume":"19","author":"Moscicki","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0070","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/ijc.27418","article-title":"Low risk of cervical intraepithelial neoplasia grade 2\/3 after re-appearance of type-specific carcinogenic HPV","volume":"131","author":"Rodriguez","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1258\/ijsa.2009.009280","article-title":"Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3","volume":"22","author":"Syrjanen","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0080","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0b013e31818c9222","article-title":"Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology","volume":"112","author":"Moscicki","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0085","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmv.21750","article-title":"Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women","volume":"82","author":"Nielsen","year":"2010","journal-title":"J Med Virol"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.05.089_bib0435","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immune deficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jadohealth.2008.10.006","article-title":"Factors that influence the rate of epithelial maturation in the cervix in healthy young women","volume":"44","author":"Hwang","year":"2009","journal-title":"J Adolesc Health"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjc.6604974","article-title":"Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries","volume":"100","author":"Louie","year":"2009","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.vaccine.2012.05.089_bib0105","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djq436","article-title":"Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort","volume":"102","author":"Safaeian","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2012.05.089_bib0110","series-title":"27th International Papillomavirus Conference and Clinical Workshop","article-title":"Reactivation vs. New HPV-16 Detection","author":"Moscicki","year":"2011"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25400","article-title":"Association between toll-like receptor expression and human papillomavirus type 16 persistence","volume":"128","author":"Daud","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/IGC.0b013e3181a388c4","article-title":"Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection","volume":"19","author":"Farhat","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"21","key":"10.1016\/j.vaccine.2012.05.089_bib0125","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1158\/0008-5472.CAN-10-0621","article-title":"Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity","volume":"70","author":"Trottier","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/vim.2009.0055","article-title":"Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV","volume":"22","author":"Malik","year":"2009","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/jir209","article-title":"A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study","volume":"204","author":"Wentzensen","year":"2011","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2012.05.089_bib0140","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"9686","key":"10.1016\/j.vaccine.2012.05.089_bib0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.089_bib0150","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/657083","article-title":"Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections","volume":"202","author":"Xi","year":"2010","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0155","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3201\/eid1406.0706162","article-title":"Transmission of human papillomavirus in heterosexual couples","volume":"14","author":"Hernandez","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0160","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.06.069","article-title":"Is the treatment of CIN 2 always necessary in women under 25 years old?","volume":"205","author":"McAllum","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.05.089_bib0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-9-119","article-title":"Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model","volume":"9","author":"Insinga","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.089_bib0180","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.25630","article-title":"Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study","volume":"128","author":"Matsumoto","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.05.089_bib0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-5956-9-36","article-title":"Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies","volume":"9","author":"Uleberg","year":"2011","journal-title":"Proteome Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.089_bib0190","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jir644","article-title":"Genital Transmission of Human Papillomavirus in Recently Formed Heterosexual Couples","volume":"204","author":"Burchell","year":"2011","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2012.05.089_bib0195","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/651607","article-title":"Reduced clearance of penile human papillomavirus infection in uncircumcised men","volume":"201","author":"Hernandez","year":"2010","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2012.05.089_bib0200","series-title":"The 26th International Papillomavirus Conference","article-title":"HPV transmission in heterosexually active couples over 12 months. Oral presentation 316","author":"Mbulawa","year":"2010"},{"key":"10.1016\/j.vaccine.2012.05.089_bib0205","series-title":"26th International Papillomavirus Conference","article-title":"Concordance and transmission of human papillomavirus. Poster P-612","author":"Widdice","year":"2010"},{"issue":"9769","key":"10.1016\/j.vaccine.2012.05.089_bib0210","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0215","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwp466","article-title":"Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus","volume":"171","author":"Bogaards","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canep.2010.10.005","article-title":"The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing","volume":"35","author":"Baay","year":"2011","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.089_bib0225","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/ijc.22209","article-title":"Flat penile lesions: the infectious \u201cinvisible\u201d link in the transmission of human papillomavirus","volume":"119","author":"Bleeker","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.089_bib0230","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2005.09.001","article-title":"Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions","volume":"35","author":"Monnier-Benoit","year":"2006","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.089_bib0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.10846","article-title":"Viral load as a predictor of the risk of cervical intraepithelial neoplasia","volume":"103","author":"Schlecht","year":"2003","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0240","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/431978","article-title":"Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads","volume":"41","author":"Bleeker","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0245","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ije\/dyp350","article-title":"Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium","volume":"39","author":"Heck","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.05.089_bib0250","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/597755","article-title":"Oral sexual behaviors associated with prevalent oral human papillomavirus infection","volume":"199","author":"D'Souza","year":"2009","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0255","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/529207","article-title":"Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study","volume":"197","author":"Goodman","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.089_bib0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","volume":"138","author":"Piketty","year":"2003","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.vaccine.2012.05.089_bib0270","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/651620","article-title":"Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study","volume":"201","author":"Goodman","year":"2010","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.089_bib0275","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0280","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1158\/1055-9965.EPI-10-0226","article-title":"Detection of genital HPV types in fingertip samples from newly sexually active female university students","volume":"19","author":"Winer","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jadohealth.2010.01.006","article-title":"Human papillomavirus concordance in heterosexual couples","volume":"47","author":"Widdice","year":"2010","journal-title":"J Adolesc Health"},{"issue":"6","key":"10.1016\/j.vaccine.2012.05.089_bib0290","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ijc.24097","article-title":"Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study","volume":"124","author":"Giuliano","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents","volume":"203","author":"Vardas","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/infdis\/jiq016","article-title":"Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men","volume":"203","author":"Goldstone","year":"2011","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.089_bib0305","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/OLQ.0b013e31822154f9","article-title":"The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: The HIM study","volume":"38","author":"Nyitray","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/OLQ.0b013e3182387abd","article-title":"Male circumcision and genital Human Papillomavirus: a systematic review and meta-analysis","volume":"39","author":"Albero","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.089_bib0315","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/653708","article-title":"Consistent condom use is associated with lower prevalence of human papillomavirus infection in men","volume":"202","author":"Nielson","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1055-9965.EPI-11-0591","article-title":"Smoking and human papillomavirus (HPV) infection in the HPV in men (HIM) study","volume":"21","author":"Schabath","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0325","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.24770","article-title":"Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men","volume":"126","author":"Smith","year":"2010","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0330","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/604729","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004","volume":"200","author":"Markowitz","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0335","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/1055-9965.EPI-10-1160","article-title":"Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study)","volume":"20","author":"Lu","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.089_bib0340","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/652184","article-title":"Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda","volume":"201","author":"Gray","year":"2010","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.089_bib0345","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/0008-5472.CAN-11-0751","article-title":"Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men","volume":"72","author":"Lu","year":"2011","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2012.05.089_bib0350","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ypmed.2011.08.002","article-title":"Genital HPV infection and related lesions in men","volume":"53","author":"Anic","year":"2011","journal-title":"Prev Med"},{"issue":"S5","key":"10.1016\/j.vaccine.2012.05.089_bib0440","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0360","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.089_bib0365","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/652187","article-title":"Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study","volume":"201","author":"Nyitray","year":"2010","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0370","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1086\/596758","article-title":"Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study","volume":"48","author":"Shvetsov","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.05.089_bib0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/421467","article-title":"Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type","volume":"190","author":"Moscicki","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.089_bib0380","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/0003-4819-149-5-200809020-00004","article-title":"Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men","volume":"149","author":"Chin-Hong","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.089_bib0385","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/AOG.0b013e3181ea1834","article-title":"Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia","volume":"116","author":"Santoso","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.089_bib0390","doi-asserted-by":"crossref","first-page":"115.e111","DOI":"10.1016\/j.ajog.2011.03.011","article-title":"Association between genital intraepithelial lesions and anal squamous intraepithelial lesions in HIV-negative women","volume":"205","author":"Jacyntho","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.05.089_bib0395","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/bjs.7218","article-title":"Human papillomavirus infection and anal dysplasia in renal transplant recipients","volume":"97","author":"Patel","year":"2010","journal-title":"Br J Surg"},{"issue":"7676","key":"10.1016\/j.vaccine.2012.05.089_bib0400","first-page":"969","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ."},{"issue":"14","key":"10.1016\/j.vaccine.2012.05.089_bib0405","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.vaccine.2012.05.089_bib0410","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0415","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.vaccine.2012.05.089_bib0420","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.vaccine.2012.05.089_bib0425","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djr283","article-title":"Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T02:27:49Z","timestamp":1540088869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":85,"alternative-id":["S0264410X12009486"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}